ECSP034813A - Arilsulfonamidas como agentes antivirales - Google Patents
Arilsulfonamidas como agentes antiviralesInfo
- Publication number
- ECSP034813A ECSP034813A EC2003004813A ECSP034813A ECSP034813A EC SP034813 A ECSP034813 A EC SP034813A EC 2003004813 A EC2003004813 A EC 2003004813A EC SP034813 A ECSP034813 A EC SP034813A EC SP034813 A ECSP034813 A EC SP034813A
- Authority
- EC
- Ecuador
- Prior art keywords
- antiviral agents
- arilsulfonamids
- well
- substituents
- procedures
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención muestra que los sustituyentes R1, R2, R3, R4 así como A y X tienen los significados dados, así como a procedimientos para su preparación y a su uso como agentes antivirales, especialmente frente a citomegalovirus.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10119137 | 2001-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP034813A true ECSP034813A (es) | 2003-12-01 |
Family
ID=7681939
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2003004813A ECSP034813A (es) | 2001-04-19 | 2003-10-17 | Arilsulfonamidas como agentes antivirales |
Country Status (9)
Country | Link |
---|---|
KR (1) | KR20030088509A (es) |
AR (1) | AR034309A1 (es) |
CO (1) | CO5540388A2 (es) |
DE (1) | DE10148598A1 (es) |
EC (1) | ECSP034813A (es) |
GT (1) | GT200200075A (es) |
PE (1) | PE20021061A1 (es) |
SV (1) | SV2003000995A (es) |
ZA (1) | ZA200307892B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
CA2494164A1 (en) | 2002-08-23 | 2004-03-04 | Rigel Pharmaceuticals, Inc. | Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
WO2004058253A1 (en) * | 2002-12-18 | 2004-07-15 | Cytovia, Inc. | 3,5-disubstituted-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
DE10300109A1 (de) * | 2003-01-07 | 2004-07-15 | Bayer Healthcare Ag | Methode zur Inhibition der Replikation von Herpesviren |
US7326790B2 (en) | 2003-05-02 | 2008-02-05 | Rigel Pharmaceuticals, Inc. | Diphenylisoxazole compounds and hydro isomers thereof |
US8580842B2 (en) | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
WO2005049065A2 (en) | 2003-11-19 | 2005-06-02 | Rigel Pharmaceuticals, Inc. | Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
CN101203498A (zh) | 2005-05-02 | 2008-06-18 | 里格尔药品股份有限公司 | 包括可代谢部分的杂环抗病毒化合物及其用途 |
US8486979B2 (en) | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
CA2707671C (en) | 2007-12-07 | 2016-02-02 | Abbott Gmbh & Co. Kg | 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
BRPI0820668A2 (pt) | 2007-12-07 | 2017-08-22 | Abbott Gmbh & Co Kg | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina |
WO2010009775A1 (de) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen |
MX2010006202A (es) | 2007-12-07 | 2011-03-04 | Abbott Gmbh & Co Kg | Derivados de oxindol substituidos por amidometil y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina. |
WO2010138600A2 (en) | 2009-05-29 | 2010-12-02 | Abbott Laboratories | Pharmaceutical compositions for the treatment of pain |
-
2001
- 2001-10-02 DE DE10148598A patent/DE10148598A1/de not_active Withdrawn
-
2002
- 2002-04-08 KR KR10-2003-7013617A patent/KR20030088509A/ko not_active Application Discontinuation
- 2002-04-17 AR ARP020101392A patent/AR034309A1/es unknown
- 2002-04-18 SV SV2002000995A patent/SV2003000995A/es not_active Application Discontinuation
- 2002-04-18 PE PE2002000323A patent/PE20021061A1/es not_active Application Discontinuation
- 2002-04-18 GT GT200200075A patent/GT200200075A/es unknown
-
2003
- 2003-10-09 ZA ZA200307892A patent/ZA200307892B/en unknown
- 2003-10-17 EC EC2003004813A patent/ECSP034813A/es unknown
- 2003-11-19 CO CO03102172A patent/CO5540388A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ZA200307892B (en) | 2004-10-11 |
GT200200075A (es) | 2002-12-24 |
KR20030088509A (ko) | 2003-11-19 |
DE10148598A1 (de) | 2002-10-24 |
AR034309A1 (es) | 2004-02-18 |
CO5540388A2 (es) | 2005-07-29 |
PE20021061A1 (es) | 2002-12-12 |
SV2003000995A (es) | 2003-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP034813A (es) | Arilsulfonamidas como agentes antivirales | |
UY27226A1 (es) | Pirazolopirimidinas como agentes terapéuticos | |
ECSP045245A (es) | N-aril-2-oxazolidinona-5-carboxamidas y sus derivados | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ES2094380T3 (es) | Nuevos pirazolilpirazoles sustituidos, procedimientos para su preparacion, asi como compuestos intermedios, y su uso como herbicidas. | |
SV2004001432A (es) | 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv | |
UY28342A1 (es) | Nuevos compuestos | |
PA8595901A1 (es) | "n-arilheterociclos sustituidos, procedimientos para su preparacion, y su empleo como medicamentos | |
HN2002000300A (es) | Nuevos derivados de piperazina | |
UY28348A1 (es) | Compuestos novedosos | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
ECSP066481A (es) | Formulaciones que contienen cobre | |
ES2165523T3 (es) | Derivados de la ciclopentano-1,3-diona. | |
PA8575601A1 (es) | Procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso | |
UY27263A1 (es) | Nuevas arilsulfonamidas como agentes antivirales | |
ECSP044999A (es) | Agentes antidiabeticos | |
UY28694A1 (es) | Nuevos compuestos | |
AR035284A1 (es) | Formulaciones en combinacion de derivados de propanol-amina sustituidos con arilo, junto con otras sustancias activas y su utilizacion | |
GT199900010A (es) | Nuevas sulfonamidas naftil- y anilido-substituidas. | |
AR030537A1 (es) | Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos | |
AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
AR027575A1 (es) | Benzoilciclohexenonas substituidas | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
AR025796A1 (es) | Quinazolinonas | |
PA8557201A1 (es) | Compuestos basicos lineales que tienen actividad antagonista de nk-2 y su formulaciones |